Expression of Pleiotrophin and its Receptors in Human Placenta Suggests Roles in Trophoblast Life Cycle and Angiogenesis

Placenta

Volumn 30, Issue 7, 2009, Pages 649-653

  Ball, M ^a   Carmody, M ^a   Wynne, F ^a   Dockery, P ^b   Aigner, A ^c   Cameron, I ^d   Higgins, J ^a   Smith, S D ^e   Aplin, J D ^e   Moore, T ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Anaplastic lymphoma kinase; Extravillous trophoblast; Pleiotrophin; Pre eclampsia; Receptor type protein tyrosine phosphatase; Syncytiotrophoblast; Syndecan

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; PLEIOTROPHIN; PROTEIN TYROSINE PHOSPHATASE; RECEPTOR PROTEIN TYROSINE PHOSPHATASE BETA; RECEPTOR PROTEIN TYROSINE PHOSPHATASE ZETA; SYNDECAN 1; SYNDECAN 3; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CELL CYCLE; CELL LINE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MATERNAL BLOOD; PHYLOGENY; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TROPHOBLAST;

CARRIER PROTEINS; CELL CYCLE; CELL LINE, TUMOR; CELL LINEAGE; CYTOKINES; FEMALE; GENE EXPRESSION; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PLACENTAL CIRCULATION; PREGNANCY; PROTEIN-TYROSINE KINASES; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 5; SYNDECAN-1; SYNDECAN-2; TROPHOBLASTS;

EID: 67349117065     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2009.05.001     Document Type: Article

References (27)

1. Stoica G.E., Kuo A., Aigner A., Sunitha I., Souttou B., Malerczyk C., et al. Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin. J Biol Chem 276 20 (2001) 16772-16779
2. Maeda N., Nishiwaki T., Shintani T., Hamanaka H., and Noda M. 6B4 proteoglycan/phosphacan, an extracellular variant of receptor-like protein-tyrosine phosphatase zeta/RPTPbeta, binds pleiotrophin/heparin-binding growth-associated molecule (HB-GAM). J Biol Chem 271 35 (1996) 21446-21452
3. Kinnunen T., Raulo E., Nolo R., Maccarana M., Lindahl U., and Rauvala H. Neurite outgrowth in brain neurons induced by heparin-binding growth-associated molecule (HB-GAM) depends on the specific interaction of HB-GAM with heparan sulfate at the cell surface. J Biol Chem 271 4 (1996) 2243-2248
4. Deepa S.S., Yamada S., Zako M., Goldberger O., and Sugahara K. Chondroitin sulfate chains on syndecan-1 and syndecan-4 from normal murine mammary gland epithelial cells are structurally and functionally distinct and cooperate with heparan sulfate chains to bind growth factors. A novel function to control binding of midkine, pleiotrophin, and basic fibroblast growth factor. J Biol Chem 279 36 (2004) 37368-37376
5. Said E.A., Courty J., Svab J., Delbe J., Krust B., and Hovanessian A.G. Pleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolin. FEBS J 272 18 (2005) 4646-4659
6. Muramatsu H., Zou P., Kurosawa N., Ichihara-Tanaka K., Maruyama K., Inoh K., et al. Female infertility in mice deficient in midkine and pleiotrophin, which form a distinct family of growth factors. Genes Cells 11 12 (2006) 1405-1417
7. Schulte A.M., Lai S., Kurtz A., Czubayko F., Riegel A.T., and Wellstein A. Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ-line insertion of an endogenous retrovirus. Proc Natl Acad Sci USA 93 25 (1996) 14759-14764
8. Schulte A.M., and Wellstein A. Structure and phylogenetic analysis of an endogenous retrovirus inserted into the human growth factor gene pleiotrophin. J Virol 72 7 (1998) 6065-6072
9. Park T.J., Jeong B.R., Tateno C., Kim H.S., Ogawa T., Lim I.K., et al. Pleiotrophin inhibits transforming growth factor beta1-induced apoptosis in hepatoma cell lines. Mol Carcinog 47 10 (2008) 784-796
10. Weber D., Klomp H.J., Czubayko F., Wellstein A., and Juhl H. Pleiotrophin can be rate-limiting for pancreatic cancer cell growth. Cancer Res. 60 18 (2000) 5284-5288
11. Aigner A., Brachmann P., Beyer J., Jäger R., Raulais D., Vigny M., et al. Marked increase of the growth factors pleiotrophin and fibroblast growth factor-2 in serum of testicular cancer patients. Ann Oncol 14 10 (2003) 1525-1529
12. Anjum N., Baker P.N., Robinson N.J., and Aplin J.D. Maternal celiac disease autoantibodies bind directly to syncytiotrophoblast and inhibit placental tissue transglutaminase activity. Reprod Biol Endocrinol 7 (2009) 16
13. Bowden E.T., Stoica G.E., and Wellstein A. Anti-apoptotic signaling of pleiotrophin through its receptor, anaplastic lymphoma kinase. J Biol Chem 277 39 (2002) 35862-35868
14. Li J., Wei H., Chesley A., Moon C., Krawczyk M., Volkova M., et al. The pro-angiogenic cytokine pleiotrophin potentiates cardiomyocyte apoptosis through inhibition of endogenous AKT/PKB activity. J Biol Chem 282 48 (2007) 34984-34993
15. Jokimaa V.I., Kujari H.P., Ekholm E.M., Inki P.L., and Anttila L. Placental expression of syndecan 1 is diminished in preeclampsia. Am J Obstet Gynecol 183 6 (2000) 1495-1498
16. Norris K., Norris F., Kono D.H., Vestergaard H., Pedersen O., Theofilopoulos A.N., et al. Expression of protein-tyrosine phosphatases in the major insulin target tissues. FEBS Lett 415 3 (1997) 243-248
17. Perez-Pinera P., Chang Y., and Deuel T.F. Pleiotrophin, a multifunctional tumor promoter through induction of tumor angiogenesis, remodeling of the tumor microenvironment, and activation of stromal fibroblasts. Cell Cycle 6 23 (2007) 2877-2883
18. Perez-Pinera P., Zhang W., Chang Y., Vega J.A., and Deuel T.F. Anaplastic lymphoma kinase is activated through the pleiotrophin/receptor protein-tyrosine phosphatase beta/zeta signalling pathway: an alternative mechanism of receptor tyrosine kinase activation. J Biol Chem 282 39 (2007) 28683-28690
19. Antoine M., Tag C.G., Wirz W., Borkham-Kamphorst E., Sawitza I., Gressner A.M., et al. Upregulation of pleiotrophin expression in rat hepatic stellate cells by PDGF and hypoxia: implications for its role in experimental biliary liver fibrogenesis. Biochem Biophys Res Commun 337 4 (2005) 1153-1164
20. Herradon G., Ezquerra L., Nguyen T., Vogt T.F., Bronson R., Silos-Santiago I., et al. Pleiotrophin is an important regulator of the renin-angiotensin system in mouse aorta. Biochem Biophys Res Commun 324 3 (2004) 1041-1047
21. Ezquerra L., Herradón G., Nguyen T., Vogt T.F., Bronson R., Silos-Santiago I., et al. Pleiotrophin is a major regulator of the catecholamine biosynthesis pathway in mouse aorta. Biochem Biophys Res Commun 323 2 (2004) 512-517
22. Kokolakis G., Mikelis C., Papadimitriou E., Courty J., Karetsou E., and Katsoris P. Effect of heparin affin regulatory peptide on the expression of vascular endothelial growth factor receptors in endothelial cells. Vivo 20 5 (2006) 629-635
23. Sharifi B.G., Zeng Z., Wang L., Song L., Chen H., Qin M., et al. Pleiotrophin induces transdifferentiation of monocytes into functional endothelial cells. Arterioscler Thromb Vasc Biol 26 6 (2006) 1273-1280
24. Heiss C., Wong M.L., Block V.I., Lao D., Real W.M., Yeghiazarians Y., et al. Pleiotrophin induces nitric oxide dependent migration of endothelial progenitor cells. J Cell Physiol 215 2 (2008) 366-373
25. Christman K.L., Fang Q., Kim A.J., Sievers R.E., Fok H.H., Candia A.F., et al. Pleiotrophin induces formation of functional neovasculature in vivo. Biochem Biophys Res Commun 332 4 (2005) 1146-1152
26. Héroult M., Bernard-Pierrot I., Delbé J., Hamma-Kourbali Y., Katsoris P., Barritault D., et al. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. Oncogene 23 9 (2004) 1745-1753
27. Zhang N., Zhong R., Perez-Pinera P., Herradon G., Ezquerra L., Wang Z.Y., et al. Identification of the angiogenesis signaling domain in pleiotrophin defines a mechanism of the angiogenic switch. Biochem Biophys Res Commun 343 2 (2006) 653-658